Zantac's Active Ingredient is Found to Increase the Risk of Cancer.

A man looking at a Zantac bottle
Breaking News
on shelf

FDA calls for heartburn drug Zantac to be pulled from market immediately

(CNN) The US Food and Drug Administration is requesting that manufacturers pull all prescription and over-the-counter ranitidine drugs, known by the brand name Zantac, from the market immediately.


Makers of generic Zantac (Ranitidine), Sandoz and Novartis, have issued a recall after Carcinogen concerns.

Zantac has been Found to Contain High Levels of the Cancer Causing Chemical, NDMA

Drug-safety officials are looking into whether the heartburn medication Zantac contains levels of the probable carcinogen NDMA that could pose a danger to users.

Ranitidine, as the drug is known in generic form, is an antacid and antihistamine used to treat and prevent a range of gastrointestinal disorders.

Independant Test Discovered Carcinogens

The online pharmacy, Valisure independently tested ranitidine, brand name Zantac. In a Citizen Petition to the FDA, they said that they found, “extremely high levels of NDMA, a probable human carcinogen, in every lot tested, across multiple manufacturers and dosage forms.

Zantac box

Zantac is used to treat the following conditions:

  •  Gastroesophageal Reflux Disease (GERD)
  •  Acid Indigestion
  •  Heart Burn
  •  Erosive Esophagitis
  •  Zollinger-Ellison Syndrome

Let Us File Your Lawsuit

Drug companies have an obligation to inform the public about any harmful side effects of drugs they create and market. When a drug maker fails to provide adequate warnings about the risks related to the use of a particular drug, it could be held liable in lawsuits for injuries and damages that may result. Let us help you get a qualified opinion on your potential Ranitidine lawsuit. We will charge no fee unless your case is successful.

Attorney checking notes of a Roundup Case